Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Expression profile of Oct-4 lung cancer-specific marker prior and subsequent to a salirasib treatment regime.

Ao X, Zhou J, Liang HL, Jiang M, Li HS.

Oncol Lett. 2017 Nov;14(5):5145-5148. doi: 10.3892/ol.2017.6868. Epub 2017 Sep 1.

2.

Prediction of lung cancer patient survival via supervised machine learning classification techniques.

Lynch CM, Abdollahi B, Fuqua JD, de Carlo AR, Bartholomai JA, Balgemann RN, van Berkel VH, Frieboes HB.

Int J Med Inform. 2017 Dec;108:1-8. doi: 10.1016/j.ijmedinf.2017.09.013. Epub 2017 Sep 25.

PMID:
29132615
3.

GAB2 Amplification in Squamous Cell Lung Cancer of Non-Smokers.

Park YR, Bae SH, Ji W, Seo EJ, Lee JC, Kim HR, Jang SJ, Choi CM.

J Korean Med Sci. 2017 Nov;32(11):1784-1791. doi: 10.3346/jkms.2017.32.11.1784.

4.

Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies.

Zhu QG, Zhang SM, Ding XX, He B, Zhang HQ.

Oncotarget. 2017 Apr 10;8(34):57680-57692. doi: 10.18632/oncotarget.17016. eCollection 2017 Aug 22. Review.

5.

Application of unsupervised analysis techniques to lung cancer patient data.

Lynch CM, van Berkel VH, Frieboes HB.

PLoS One. 2017 Sep 14;12(9):e0184370. doi: 10.1371/journal.pone.0184370. eCollection 2017.

6.

Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.

Tong M, Wang J, Jiang N, Pan H, Li D.

PLoS One. 2017 Aug 10;12(8):e0182282. doi: 10.1371/journal.pone.0182282. eCollection 2017. Review.

7.

Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.

Tao MH, Dai Q, Chen S, Freudenheim JL, Rohan T, Wakelee H, Datta M, Wactawski-Wende J.

Lung Cancer. 2017 Aug;110:42-47. doi: 10.1016/j.lungcan.2017.06.002. Epub 2017 Jun 8.

PMID:
28676217
8.

Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis.

Tsiambas E, Mastronikolis NS, Lefas AY, Georgiannos SN, Ragos V, Fotiades PP, Tsoukalas N, Kavantzas N, Karameris A, Peschos D, Patsouris E, Syrigos K.

In Vivo. 2017 Jul-Aug;31(4):641-648.

9.

Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.

Azar FE, Azami-Aghdash S, Pournaghi-Azar F, Mazdaki A, Rezapour A, Ebrahimi P, Yousefzadeh N.

BMC Health Serv Res. 2017 Jun 19;17(1):413. doi: 10.1186/s12913-017-2374-1.

10.

Cancer survival in Qidong between 1972 and 2011: A population-based analysis.

Chen JG, Zhu J, Zhang YH, Zhang YX, Yao DF, Chen YS, Lu JH, Ding LL, Chen HZ, Zhu CY, Yang LP, Zhu YR, Qiang FL.

Mol Clin Oncol. 2017 Jun;6(6):944-954. doi: 10.3892/mco.2017.1234. Epub 2017 May 3.

11.

ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer.

Richter AM, Kiehl S, Köger N, Breuer J, Stiewe T, Dammann RH.

Clin Epigenetics. 2017 Jun 2;9:60. doi: 10.1186/s13148-017-0360-4. eCollection 2017.

12.

Clinical features and biological markers of lung cancer-associated stroke.

Xie X, Chen L, Zeng J, Qin C, Cheng D, Wei X, Liang Z.

J Int Med Res. 2016 Dec;44(6):1483-1491. doi: 10.1177/0300060516666398. Epub 2016 Nov 10.

13.

Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study.

Fehringer G, Brenner DR, Zhang ZF, Lee YA, Matsuo K, Ito H, Lan Q, Vineis P, Johansson M, Overvad K, Riboli E, Trichopoulou A, Sacerdote C, Stucker I, Boffetta P, Brennan P, Christiani DC, Hong YC, Landi MT, Morgenstern H, Schwartz AG, Wenzlaff AS, Rennert G, McLaughlin JR, Harris CC, Olivo-Marston S, Orlow I, Park BJ, Zauderer M, Barros Dios JM, Ruano Raviña A, Siemiatycki J, Koushik A, Lazarus P, Fernández-Somoano A, Tardon A, Le Marchand L, Brenner H, Saum KU, Duell EJ, Andrew AS, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Holcatova I, Pesatori AC, Consonni D, Olsson A, Straif K, Hung RJ.

Int J Cancer. 2017 May 1;140(9):1976-1984. doi: 10.1002/ijc.30618. Epub 2017 Feb 27.

PMID:
28120396
14.

The effect of smoking on lung cancer: ethnic differences and the smoking paradox.

Jung KJ, Jeon C, Jee SH.

Epidemiol Health. 2016 Dec 20;38:e2016060. doi: 10.4178/epih.e2016060. eCollection 2016. Review.

15.

Spatiotemporal Variations in Lung Cancer Mortality in China between 2006 and 2012: A Multilevel Analysis.

Liu Y, Astell-Burt T, Liu J, Yin P, Feng X, You J, Page A, Zhou M, Wang L.

Int J Environ Res Public Health. 2016 Dec 16;13(12). pii: E1252. doi: 10.3390/ijerph13121252.

16.
17.

Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.

Wu X, Cheng J, Yang K.

Int J Mol Sci. 2016 Sep 22;17(10). pii: E1597. doi: 10.3390/ijms17101597.

18.

Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers.

Malhotra J, Waterboer T, Pawlita M, Michel A, Cai Q, Zheng W, Gao YT, Lan Q, Rothman N, Langseth H, Grimsrud TK, Yuan JM, Koh WP, Wang R, Arslan AA, Zeleniuch-Jacquotte A, Boffetta P.

Br J Cancer. 2016 Oct 25;115(9):1131-1139. doi: 10.1038/bjc.2016.285. Epub 2016 Sep 15.

19.

Targeting metabolic peculiarities: a potentially novel therapeutic approach for KRAS-mutant lung cancer?

Abdel-Rahman O.

J Thorac Dis. 2016 Aug;8(8):E794-5. doi: 10.21037/jtd.2016.06.72. No abstract available.

20.

Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma.

Li M, Deng F, Qian LT, Meng SP, Zhang Y, Shan WL, Zhang XL, Wang BL.

Oncol Lett. 2016 Sep;12(3):1953-1958. Epub 2016 Jul 12.

Supplemental Content

Support Center